Afterburner, Inc. Fighter Pilot Consultants Deliver Leading Results Flawless Execution(SM) Keynote Speech and Workshop in Napa, California

Share Article

Fighter Pilot Keynote Speakers Deliver Continuous Improvement Process Seminar to Biotechnology Industry Leader

Afterburner Inc.'s workshop and keynote speech help leading biotechnology firm improve its business processes and close execution gaps.

We are excited to continue our ongoing relationship with Genentech, allowing our corporate partner to further its executional efficiencies through our leadership development programs.

Afterburner, Inc., a leading corporate team building, training and consulting firm based in Atlanta, Ga., and the global authority on the Flawless Execution(SM) model, recently delivered a Leading Results continuous improvement process keynote speech to Genentech, a biotechnology industry leader.

Genentech has worked in the field of biotechnology for over 30 years, using human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious medical conditions. Offering multiple products and services to prevent, diagnose and treat diseases, Genentech works to improve healthcare and the quality of life by respecting the needs of the individual, society and the environment. Genentech employees and company leaders attended Afterburner's Leading Results seminar, a powerful combination of a Flawless Execution(SM) keynote speech and planning workshop, to learn how to apply the Afterburner continuous improvement process of Plan, Brief, Execute and Debrief to the biotechnology industry.

Fighter pilot keynote speaker, Jim "Boots" Demarest, presented the Flawless Execution(SM) keynote speech to the biotechnology industry leader, educating Genentech employees about how to implement the zero-tolerance-for-error continuous improvement process to accelerate performance, increase teamwork and integrate organizational change. After the keynote speech, Genentech attendees participated in a planning workshop, where they learned how to leverage the Afterburner Six-Step Mission Planning Process in real-life situations.

"We are excited to continue our ongoing relationship with Genentech, allowing our corporate partner to further its executional efficiencies through our leadership development programs," said Jim "Boots" Demarest. "Afterburner is pleased to once again have the opportunity to collaborate with a leader in the biotechnology industry, as they are able to utilize our zero-tolerance-for-error business process improvement initiatives to close execution gaps and align its team."

To learn more about Afterburner's Flawless Execution(SM) continuous improvement process, or to schedule a Leading Results keynote speech and planning workshop with our experienced fighter pilot keynote speakers, visit or call 877-765-5607.

About Afterburner Equip

Afterburner Inc., founded in 1996 by Jim "Murph" Murphy, a U.S. Air Force fighter pilot, trains organizations around the world in the simple, scalable improvement processes of Flawless Execution, which encompasses the Three E's - Empower, Equip, and Embed. Equip in particular provides training, consulting, and software services through a variety of methods. With a client list that includes over 23% of the U.S. Fortune 500, Afterburner has landed on Inc. Magazine's "Inc. 500 List of America's Fastest Growing Companies" twice and has been featured regularly in publications that include the Wall Street Journal, Business Week, Financial Times, Newsweek, and Meetings and Conventions Magazine. Afterburner has also appeared on CNN, CNBC, Fox News and Bloomberg News. Learn more about Equip, Afterburner's strategic business planning solution.

About Genentech

Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, Calif. For additional information about Genentech, please visit


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Scott Leonard
Visit website